Pre-operatively determined prognostic factors in metastatic renal cell carcinoma

Eur Urol. 1997;31(3):292-6. doi: 10.1159/000474470.

Abstract

Objectives: The aim of this study was to clarify the pre-operatively determined factors affecting the prognosis in patients with metastatic renal cell carcinoma (RCC).

Methods: We analyzed 69 patients with metastatic RCC who received nephrectomy. Multivariate analysis by Cox's proportional hazards model and survival studies were applied.

Results: Tumor thrombus in a renal vein or vena cava was the most significant poor-prognostic factor, followed by multiple-organ metastases and three or more abnormal findings of factors related to acute-phase proteins, in this order. Seven patients having these three risk factors died of cancer within 7 months after nephrectomy. On the other hand, half of the patients without risk factors survived for more than 2 years.

Conclusions: Risk status should be used for selection of metastatic-RCC patients for treatment of the primary site.

Publication types

  • Clinical Trial
  • Controlled Clinical Trial

MeSH terms

  • Acute-Phase Proteins / metabolism
  • Analysis of Variance
  • Antineoplastic Agents, Hormonal / administration & dosage
  • Antineoplastic Agents, Hormonal / therapeutic use
  • Carcinoma, Renal Cell / mortality*
  • Carcinoma, Renal Cell / secondary
  • Carcinoma, Renal Cell / surgery
  • Carcinoma, Renal Cell / therapy
  • Chemotherapy, Adjuvant
  • Humans
  • Kidney Neoplasms / mortality*
  • Kidney Neoplasms / surgery
  • Kidney Neoplasms / therapy
  • Medroxyprogesterone Acetate / therapeutic use
  • Nephrectomy
  • Prognosis
  • Proportional Hazards Models
  • Renal Veins / diagnostic imaging
  • Renal Veins / pathology
  • Risk Assessment
  • Ultrasonography
  • Venae Cavae / diagnostic imaging
  • Venae Cavae / pathology

Substances

  • Acute-Phase Proteins
  • Antineoplastic Agents, Hormonal
  • Medroxyprogesterone Acetate